|
Market Closed -
Nasdaq
20:19:41 10/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.1400 USD | +8.69% |
|
-8.50% | -83.53% |
| 08-14 | CASI Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 08-14 | Casi Pharmaceuticals, Inc. Announces Management Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 994B | |||||
| 640B | - | - | - | ||
| 454B | |||||
| 337B | |||||
| 261B |
Select your edition
All financial news and data tailored to specific country editions
